Clinical Trials in Houston

Showing 8261-8280 of 17,885 trials

Resveratrol Trial for Relief of Pain in Pseudoachondroplasia

NCT03866200

The purpose of this study is to determine if self-administered oral resveratrol can dampen joint pain for individuals with pseudoachondroplasia compared to placebo. Another goal of this study is to evaluate side effects in this population.

Pseudoachondroplasia

The University of Texas Health Science Center, Houston6 participantsStarted Jun 2019

Houston, Texas, United States

TERMINATEDPhase 3< 1 mile

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

NCT03809481

An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Treatment of Subjects with Acute HIT (HITSOVA study)

Heparin-induced Thrombocytopenia

Aspen Global Incorporated7 participantsStarted May 2019

Gainesville, Florida, United States • Minneapolis, Minnesota, United States • Durham, North Carolina, United States +32 more locations

Resveratrol Trial for Relief of Pain in Pseudoachondroplasia

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Find Trials by Condition in Houston

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

SARS-CoV-2 OTC At Home Test

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic Impairment

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

eXciteOSA for Treatment of Mild Obstructive Sleep Apnea

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

Vitala 12 Hour Wear Test With Convex Products

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Comparison Study of 3 Ostomy Products

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata